K

Karyopharm Therapeutics Inc.

KPTI NASDAQ Healthcare · Biotechnology www.karyopharm.com
$1.81
Mkt Cap 41.0M
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$151.1M
6.2% CAGR
FCF TTM
-$59.1M
-39.1% margin
Running full 6-factor analysis…